Gene Expression in First Trimester Preeclampsia Placenta
- 1 November 2010
- journal article
- Published by SAGE Publications in Biological Research For Nursing
- Vol. 13 (2) , 134-139
Abstract
Background. The goal of this study was to further validate eight candidate genes identified in a microarray analysis of first trimester placentas in preeclampsia. Material and method. Surplus chorionic villus sampling (CVS) specimens of 4 women subsequently diagnosed with preeclampsia (PE) and 8 control women (C) without preeclampsia analyzed previously by microarray and 24 independent additional control samples (AS) were submitted for confirmatory studies by quantitative real-time polymerase chain reaction (qRT-PCR). Results. Downregulation was significant in FSTL3 in PE as compared to C and AS (p = .04). PAEP was downregulated, but the difference was only significant between C and AS (p = .002) rather than between PE and either of the control groups. Expression levels for CFH, EPAS1, IGFBP1, MMP12, and SEMA3C were not statistically different among groups, but trends were consistent with microarray results; there was no anti-correlation. S100A8 was not measurable in all samples, probably because different probes and primers were needed. Conclusions. This study corroborates reduced FSTL3 expression in the first trimester of preeclampsia. Nonsignificant trends in the other genes may require follow-up in studies powered for medium or medium/large effect sizes. qRT-PCR verification of the prior microarray of CVS may support the placental origins of preeclampsia hypothesis. Replication is needed for the candidate genes as potential biomarkers of susceptibility, early detection, and/or individualized care of maternal—infant preeclampsia.Keywords
This publication has 22 references indexed in Scilit:
- The Global Impact of Pre-eclampsia and EclampsiaSeminars in Perinatology, 2009
- Introducing Systems Biology for Nursing ScienceBiological Research For Nursing, 2009
- Cross-platform comparison of SYBR® Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) studyBMC Genomics, 2008
- High‐Throughput Quantitative Real‐Time PCRCurrent Protocols in Human Genetics, 2008
- Microarray Technology Applied to the Complex Disorder of PreeclampsiaJournal of Obstetric, Gynecologic, & Neonatal Nursing, 2008
- WHO analysis of causes of maternal death: a systematic reviewThe Lancet, 2006
- Comparison of the latest commercial short and long oligonucleotide microarray technologiesBMC Genomics, 2006
- Expression of glycodelin A in decidual tissue of preeclamptic, HELLP and intrauterine growth-restricted pregnanciesVirchows Archiv, 2005
- Long term mortality of mothers and fathers after pre-eclampsia: population based cohort studyPre-eclampsia and cardiovascular disease later in life: who is at risk?BMJ, 2001
- A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre‐eclamptic pregnanciesBJOG: An International Journal of Obstetrics & Gynaecology, 1994